[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650696":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":35,"collaborators":19,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":19,"eligibilityCriteria":43,"healthyVolunteers":39,"sex":44,"minAge":45,"maxAge":46,"enrollmentInfo":47,"targetDuration":19,"studyType":50,"phases":51,"briefSummary":53,"conditions":54,"keywords":60,"overallStatus":28,"whyStopped":19,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Kaohsiung Medical University Chung-Ho Memorial Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental group","EXPERIMENTAL","structured exercise intervention group",[13],"Other: structured exercise training",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"structured exercise training","This study utilizes a \"Personalized Precision Exercise Training Program.\" Following baseline Cardiopulmonary Exercise Testing (CPET) and comprehensive fitness assessments, physicians prescribe individualized regimens adhering to ACSM guidelines for cancer survivors, applying the FITT principle:\n\n* Aerobic Exercise: 3-5 days\u002Fweek at moderate intensity, tailored to treatment tolerance. ≥30 mins\u002Fsession, flexibly adjusted for treatment side effects. Focuses on rhythmic activities (walking, cycling).\n* Resistance Training: 2-3 days\u002Fweek (48h rest per muscle group) at 60-80% 1-RM or a load for 6-15 reps. Employs progressive overload without requiring muscular failure. Involves 8-10 major muscle groups; ≥1 set\u002Fexercise, ≥6 reps\u002Fset, with ≥60s rest between sets. Modalities adapt to patient status.\n* Flexibility Training: ≥2-3 days\u002Fweek (up to daily). Static stretches (10-30s hold, 2-4 reps, stretching to mild discomfort but avoiding pain) covering all major muscles.",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Ko-Long Lin, PhD","CONTACT","886-978-862-831","klin967@gmail.com",[27],{"facility":5,"status":28,"city":29,"state":30,"zip":31,"country":30,"countryCode":32,"cosmosGeoPoint":19,"geoPoint":19,"contacts":33},"RECRUITING","Kaohsiung","Taiwan","807","TW",[34],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},{"type":36,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100650696","development-and-dissemination-of-exercise-prescription-and-intervention-for-cancer-populations-100650696",false,"NCT07751783","Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations","A Program for the Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations","Inclusion Criteria:\n\n1. Aged 18 to 80 years.\n2. Cancer Cohorts: Pathologically confirmed diagnosis of AJCC TNM stage I-III, and having completed curative-intent treatment (including surgery ± adjuvant chemotherapy\u002Fradiotherapy, etc) for at least 2 months.\n3. Cancer cohort must have an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0-2.\n4. Ability to comply with weekly structured exercise training (3-4 professionally supervised sessions per week) and willingness to accept telephone follow-ups or report exercise status via exercise logs\u002Fwearable devices.\n5. Self-reported failure to meet the following physical activity guidelines within the past 3 months: at least 150 minutes of moderate-intensity aerobic exercise per week OR at least 75 minutes of vigorous-intensity aerobic exercise per week; AND no regular resistance training (≥ 2 sessions per week) within the past 3 months.\n\nExclusion Criteria:\n\n1. Cardiovascular instability: History of acute coronary syndrome (ACS), myocardial infarction (MI), acute exacerbation of heart failure, or hospitalization for heart failure within the past 3 months; unstable angina; uncontrolled arrhythmia; or uncontrolled hypertension (resting blood pressure \\> 180\u002F110 mmHg).\n2. Hypoxemia: Resting oxygen saturation (SpO2) \\\u003C 90%.\n3. Metabolic instability: Severe hypoglycemic event or diabetic ketoacidosis (DKA) within the past 3 months.\n4. Musculoskeletal or neurological risks: Unstable bone metastasis or bone metastasis with a high risk of fracture; recent major fracture or orthopedic surgery where weight-bearing is not yet permitted; or other severe neuromuscular diseases that compromise the safety of exercise.\n5. Hematological risks: Thrombocytopenia (Platelet count \\\u003C 50,000\u002FμL), severe anemia (Hemoglobin \\[Hb\\] \\\u003C 8 g\u002FdL), or neutropenia (Absolute Neutrophil Count \\[ANC\\] \\\u003C 1,000\u002FμL).\n6. Deemed unsuitable for exercise intervention as determined by clinical assessment from the attending physician or study investigator.\n7. Concurrent participation in other formal exercise or weight-loss intervention programs.\n8. Inability to comprehend or complete the informed consent form, or inability to comply with the study procedures.","ALL","18 Years","80 Years",{"count":48,"type":49},150,"ESTIMATED","INTERVENTIONAL",[52],"NA","The purpose of this study is to establish a safe and systematic exercise assessment and prescription program for cancer survivors. It can be challenging for cancer patients to start exercising due to various health risks, so this study aims to create a personalized and easily reproducible workflow. The study will include cancer patients who have completed their primary curative treatments at least 2 months ago.\n\nParticipants will undergo a comprehensive health and fitness evaluation led by a study physician. This evaluation includes:\n\n* A review of medical history and cardiovascular risk.\n* Functional physical fitness tests.\n* Cardiopulmonary Exercise Testing (CPET) to carefully evaluate heart and lung function during physical exertion.\n* A musculoskeletal ultrasound, if deemed necessary. Based on these combined results, the medical team will determine each participant's exercise risk level and design a personalized exercise prescription. Participants will then be assigned to an appropriate and safe exercise setting.\n\nTo ensure safety and maximize health benefits, the study includes a continuous tracking system. Participants will report their exercise progress every 4 weeks and undergo a full reassessment every 3 months. The medical team will use this feedback to safely adjust the participant's risk level and exercise prescription over time.",[55,56,57,58,59],"Cancer","Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)","Lung Cancer (Non-Small Cell)","Liver Cancer, Adult","Cancer Survivor",[61,62,63,64,65,66],"exercise","Cardiopulmonary Exercise Testing","cancer","Exercise prescription","Aerobic exercise","resistance exercise","2026-08-03",{"date":69,"type":70},"2026-08-07","ACTUAL",{"date":72,"type":70},"2026-03-12",{"date":74,"type":49},"2027-08-31",{"name":5,"class":6},1]